Fundraising Fox

Phagos

Ivry-Sur-Seine · Founded 2022 · Delaware corporation · 5 known investors

phagos.org ↗

Biotechnology company developing bacteriophage-based therapies to combat antibiotic-resistant bacteria.

Biotechin /phagos-biotech

Founders & leadership

AP
Alexandros PantalisExecutive Officer, Director
AJ
Adele JamesDirector
RK
Robert KniazDirector
XM
Xin MaDirector
GD
Geoffroy DubusDirector

Investors · 5

Acurio VenturesBilbao · $810K – $3.2M
Beyond CapitalLondon
Entrepreneur FirstBengaluru · $1M – $7M
Hoxton VenturesLondon · $500K – $5M
AgFunderreportedSan Francisco · $10K – $5M

Reported raises · per SEC filings

Form D private placements
▶$7.6MofferedNov 2024 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert KniazDirector
  • Xin MaDirector
  • Geoffroy DubusDirector
  • Alexandros PantalisExecutive Officer, Director
  • Adele JamesDirector
Offering amount
$7.6M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedSep 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexandros PantalisExecutive Officer, Director
  • Geoffroy DubusDirector
  • Adele JamesDirector
  • Robert KniazDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.